Content
All Posts > Content under Healthcare
Week In Review: BioSense Signs $68 Million China Deal With Neovacs For Therapeutic Vaccine
Article By:
ChinaBio® Today
Read
Saturday, February 25, 2017 3:36 PM EDT
BioSense Global, a New Jersey-Suzhou biotech, signed a $68 million option agreement with France's Neovacs for China rights to a therapeutic vaccine aimed at lupus and dermatomyositis.
Health Care Stock Market Sector: Why Smart Investors Are Paying Attention
Article By:
Taki Tsaklanos
Read
Saturday, February 25, 2017 11:57 AM EDT
The health care stock market sector is the outperforming sector in the S&P 500 in February 2017. Though this is an interesting insight for investors, the more important observation is the chart setup of the health sector.
In this article: XLV
Teleflex - Chart Of The Day
Article By:
Jim Van Meerten
Read
Saturday, February 25, 2017 10:14 AM EDT
Since the Trend Spotter signaled a buy in 12/16 the stock gained 20.34%
In this article: TFX
Actinium Offers Shareholders Several Interesting Near-Term Catalysts
Article By:
Jason Napodano
Read
Friday, February 24, 2017 12:50 PM EDT
Shares of ATNM have performed nicely over the past month, driven by the achievement of several milestones, including the hiring of a new Chief Medical Officer and initiation of a new clinical trial with Actimab-M for multiple ATNMmyeloma.
Should You Buy Valeant Pharmaceuticals Intl Inc. Stock Now, Ahead Of Earnings?
Article By:
Amigobulls
Read
Friday, February 24, 2017 10:50 AM EDT
Valeant stock presents a very aggressive risk-reward proposition going into the earnings. Wall Street currently has an average price target $22.39 indicating 35% upside from current price.
In this article: VRX
Biotech ETFs: Fidelity Biotech Fund Outperforms Ibb But Xbi Is Still The Leader
Article By:
Rod Raynovich
Read
Friday, February 24, 2017 12:30 AM EDT
Biotech stocks have outperformed the market YTD despite a bit of a sell-off recently. After two severe corrections in 2016 the Fidelity Select Biotechnology Fund has begun to emerge as a good play for less volatile larger caps in the sector.
In this article: FBIOX, IBB, FBT, XBI Also: ACAD, ARIA, INCY, REGN, SGEN, AMGN, CELG, CLVS, GILD, TSRO, QGEN, TECH, KITE
Patheon - Chart Of The Day
Article By:
Jim Van Meerten
Read
Wednesday, February 22, 2017 9:00 PM EDT
Since the Trend Spotter signaled a buy on 2/1 the stock gained 9.61%.
In this article: PTHN
Is GW Pharmaceuticals Due A Leg Up In 2017?
Article By:
Maithya Kitonyi
Read
Wednesday, February 22, 2017 4:11 PM EDT
GWPH is currently trading within reach of its all-time highs. The medical marijuana industry appears to be gaining traction in the US, and projections are it could grow 7-fold within the next 10 years.
In this article: GWPH
Sector Showcase: "Tale Of Two Halves" Of The Trump Presidency So Far For US Stock Markets
Article By:
Matt Weller
Read
Tuesday, February 21, 2017 2:29 PM EDT
Yesterday's close officially marked 70 trading days since the US election, and while plenty has changed, both for the country and the markets, it's really been a "Tale of Two Halves."